Our chairman Shi Yuanyuan and chief scientist Wang Jianxun were selected as expert members of the uation Committee of senior professional titles of light industry Engineering in Shenzhen (personalized
Recently, our chairman Shi Yuanyuan and chief scientist Wang Jianxun were selected as expert members of the Shenzhen Municipal Light Industry Engineering Senior Title Review Committee (individualized cells). The uation committee is based on the Cell technology National Laboratory as the daily work department of the professional technical qualification uation Committee of Shenzhen City, under the guidance of the Shenzhen Human Resources and Social Security Bureau and other superior relevant departments, organize experts and carry out independent professional title uation work. This marks a clearer path for the identification of professional and technical positions in the cell industry in Shenzhen, opening a broader space for the growth of professionals in the cell field. The selection of Professor Shi Yuanyuan and Professor Wang Jianxun as expert members of the Senior Title uation Committee is a high recognition of the two experts' leading technical ability, rich professional experience in the field of cell and gene therapy and their contribution to the high-quality development of the industry.
Cell industry is a new industry, and the development of core talents is the bottleneck problem restricting the development of industry. A clear vocational qualification uation path can stimulate the professional dignity of scientific and technological personnel, so that scientific and technological workers can gain a sense of social identity while obtaining a sense of technical achievement. This is an important factor for the technical talents engaged in the scientific and technological innovation industry to concentrate on their work and cultivate the spirit of craftsmanship, which can further accelerate the pace of Shenzhen's occupation of talent heights in the field of biomedicine. Shenzhen Cell Valley will always adhere to the original intention of "cells benefit all beings, genes create the future", and continue to make more contributions to the layout of cell and gene therapy industry and talents.